LAPIX plans to submit a third IND for LPX-TI641 in the first quarter of 2025 with the dermatology division at the US-FDA.

Rheumatoid arthritis is the most common inflammatory joint disorder, affecting over 60,000 people in Austria alone, with ...

That is the philosophy I carry into my ministry. Come as you are. Inform us, help us understand better, and you will want to ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

BTIG analyst Julian Harrison has maintained their bullish stance on SYRE stock, giving a Buy rating on January 14.Invest with Confidence: ...

Nearly half of us suffer from headaches — but could painkillers be making them worse? Try this chiropractor’s top tips ...

Arthritis can affect your fingers causing reduced mobility pain and swelling Read on to check the types of arthritis ...

Arthritis creams and lotions are designed to help ease the aches and pains associated with arthritis by delivering ...

A new clinical study highlighted the potential of ivarmacitinib, a selective Janus kinase (JAK) 1 inhibitor, as an effective ...